Form 8-K - Current report:
SEC Accession No. 0000950170-22-018988
Filing Date
2022-09-29
Accepted
2022-09-29 07:00:35
Documents
14
Period of Report
2022-09-29
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glto-20220929.htm   iXBRL 8-K 91228
2 EX-99.1 glto-ex99_1.htm EX-99.1 44136
3 GRAPHIC img80419653_0.jpg GRAPHIC 5036
  Complete submission text file 0000950170-22-018988.txt   273909

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glto-20220929_lab.xml EX-101.LAB 14084
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glto-20220929_pre.xml EX-101.PRE 11362
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glto-20220929.xsd EX-101.SCH 2449
8 EXTRACTED XBRL INSTANCE DOCUMENT glto-20220929_htm.xml XML 4875
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39655 | Film No.: 221277682
SIC: 2834 Pharmaceutical Preparations